跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 80 条关于
“RORγ/RORγT”
全部
80
临床试验
10
药物
60
机构
0
资讯
10
去年
AI-Driven Drug Design Platform Achieves 70% Success Rate in RORγT Inhibitor Discovery
去年
ROR1-Targeted Therapies Show Promise in Lymphoma and Solid Tumors
去年
Oncternal Therapeutics Sells ROR1-Targeting Programs to Ho'ola Therapeutics for $68 Million Deal
去年
CStone Advances CS5001 ROR1-ADC to Phase Ib Trial for First-line DLBCL Treatment
去年
Formosa Pharmaceuticals Secures Exclusive License for Novel Bispecific ADC Targeting EGFR/ROR1 Solid Tumors
去年
Huadong Medicine's ROR1-Targeting ADC HDM2005 Shows Promising Phase I Results in Relapsed Lymphomas
2年前
Pure Biologics' ROR1-Targeting Antibody, PBA-0405, Enters Phase 0 Clinical Trial for Cancer Treatment
去年
Immunome Initiates Phase 1 Trial of ROR1-Targeted ADC for B-Cell Lymphomas and Solid Tumors
2个月前
AI Accelerates Cancer Drug Discovery: SK Telecom and SK Biopharmaceuticals Identify ROR1-Targeting Compounds in Five Months
去年
Radiance Biopharma Secures $1.2 Billion Licensing Deal for Novel ROR-1 Targeted Cancer Therapy